Moreover, recent data indicate that GLO1 may be a valid molecular target for cancer chemotherapy, and pharmacological inhibitors of GLO1 were shown to have anticancer effects in vitro and in vivo [20,21,22]. This evidence concerns the gene GLO1 and cancer.